RxDoctor Payments Data

David Steves, DO

Family Medicine · Union City, PANPI 1033432828

Payments from drug & device makers

$479in general payments, 2019–2025

Across 27 payments — averaging $17.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$132
  • Amarin Pharma, Inc.$83
  • Johnson & Johnson$70
  • AbbVie$63
  • Daiichi Sankyo Inc.$33
  • Pfizer$32
  • plus $66 from 4 others

What the payments were for

  • Food & beverage$479100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$479 in reported general payments places this provider in the 55th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$45,362
Medicare patients
129
Services billed
437

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban90$94,145
XareltoRivaroxaban77$85,818
OzempicSemaglutide37$44,507
FarxigaDapagliflozin Propanediol36$37,728
JardianceEmpagliflozin34$37,198
MyrbetriqMirabegron22$27,383
JanumetSitagliptin Phos/Metformin Hcl15$26,176
JanuviaSitagliptin Phosphate23$26,057
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$26,015
Atorvastatin Calcium454$3,681
Potassium Chloride96$3,575
Levothyroxine Sodium266$2,944
Albuterol Sulfate HfaAlbuterol Sulfate92$2,566
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$2,514
Gabapentin100$2,400

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$32$94,14590 claims
Johnson & JohnsonXarelto$70$85,81877 claims
MerckJanumet, Januvia$12$52,23338 claims
Novo NordiskOzempic$132$44,50737 claims
AstraZenecaFarxiga$11$37,72836 claims
AbbVieSynthroid$63$75012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Union City

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →